Published in Br J Dermatol on April 01, 1974
Survey of the human acetylator polymorphism in spontaneous disorders. J Med Genet (1984) 1.00
Dapsone in rheumatoid arthritis. Ann Rheum Dis (1981) 0.75
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis (1999) 4.52
Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells (1996) 1.86
Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J Virol (1987) 1.84
Thymoma, acquired hypogammaglobulinaemia, lichen planus, alopecia areata. Proc R Soc Med (1974) 1.71
Absorption, metabolism and excretion of pyrazinamide in man. Tubercle (1969) 1.71
Pustular psoriasis with adrenal suppression following topical corticosteroids. Proc R Soc Med (1974) 1.69
Post-irradiation morphoea. Br J Dermatol (1989) 1.69
Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo. Proc R Soc Med (1974) 1.65
Scratching during sleep. Lancet (1973) 1.60
Acute generalized pustular bacterid. An unusual manifestation of leukocytoclastic vasculitis. Br J Dermatol (1974) 1.59
Prescribing antidepressants in general practice. Low dose tricyclic antidepressants are effective in treating major depression. BMJ (1997) 1.55
Steroid cream contaminated with Pseudomonas aeruginosa. Lancet (1966) 1.50
Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis. Tubercle (1968) 1.43
Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta. Genes Cells (1996) 1.42
Assessment of simple colorimetric procedures to determine smoking status of diabetic subjects. Clin Chem (1998) 1.40
Urine tests to monitor the self-administration of dapsone by leprosy patients. Am J Trop Med Hyg (1974) 1.39
Congestive heart failure in elderly patients. The treatment goal is improved quality, not quantity, of life. Postgrad Med (1997) 1.39
Mycosis fungoides--a disease of antigen persistence. Br J Dermatol (1974) 1.34
The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine. Biochem J (1972) 1.33
Respiratory effects of lowering tar and nicotine levels of cigarettes smoked by young male middle tar smokers. II. Results of a randomised controlled trial. J Epidemiol Community Health (1992) 1.32
Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis. Clin Pharmacol Ther (1976) 1.26
Pharmacokinetics of isoniazid metabolism in man. J Pharmacokinet Biopharm (1976) 1.22
A simple, inexpensive urine test of smoking. Thorax (1985) 1.22
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis. Am Rev Respir Dis (1986) 1.17
An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs. Br J Clin Pharmacol (1980) 1.12
Patients' beliefs about psoriasis. Trans St Johns Hosp Dermatol Soc (1970) 1.12
Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis. Br Med J (Clin Res Ed) (1987) 1.09
Pyrazinamide and other drugs in tuberculous meningitis. Lancet (1973) 1.09
A double-blind randomized controlled trial of the effect of a low- versus a middle-tar cigarette on respiratory symptoms--a feasibility study. IARC Sci Publ (1986) 1.08
A sensitive urine-test method for monitoring the ingestion of isoniazid. J Clin Pathol (1977) 1.07
Dapsone acetylation and the treatment of leprosy. Nature (1972) 1.07
Chemotherapy of leprosy. Br Med Bull (1988) 1.06
Some observations on the pharmacology of clofazimine (B663). Am J Trop Med Hyg (1974) 1.04
Studies on the determination of the minimal inhibitory concentration of 4,4'-diamino-diphenyl-sulphone (Dapsone, DDS) against Mycobacterium leprae. Lepr Rev (1971) 1.04
Identification and characterization of a DNase induced by Epstein-Barr virus. J Virol (1982) 1.03
The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema. Clin Exp Dermatol (1986) 1.02
New antibacterial drugs for the treatment of mycobacterial disease in man. Br Med Bull (1988) 1.02
The application of urine tests to monitor the regularity of dapsone self-administration. Lepr Rev (1974) 1.00
Letter: Prevalence of streptococci and staphylococci in lesions of impetigo. Br J Dermatol (1974) 0.99
Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens. Br J Clin Pharmacol (1977) 0.99
Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis. Am Rev Respir Dis (1984) 0.99
Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. Lepr Rev (1978) 0.98
Bacterial infections in diabetes mellitus. Br J Dermatol (1974) 0.97
The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis. Tubercle (1984) 0.97
Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia. J Clin Oncol (1983) 0.96
Absorption, metabolism and excretion of di(rho-aminophenyl) sulphone (dapsone) and di(rho-aminophenyl) sulphoxide in man. Br J Pharmacol Chemother (1966) 0.96
Proceedings: Primary systemic amyloidosis. Br J Dermatol (1974) 0.95
Pleural effusion and fibrosis during treatment with methysergide. Br Med J (1970) 0.93
Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells. Cancer Res (1987) 0.93
Current causes of fixed drug eruptions. Br J Dermatol (1970) 0.93
The hepatic toxicity of isoniazid among rapid and slow acetylators of the drug. Am Rev Respir Dis (1978) 0.92
Determination of the acetylator phenotype from the ratio of the urinary excretion of acetylisoniazid to acid-labile isoniazid: a study in Finnish Lapland. Tubercle (1973) 0.91
Pemphigoid and malignancy. Br J Cancer (1968) 0.91
Assay of rifampicin in serum. J Clin Pathol (1974) 0.91
Diabetes mellitus, sarcoidosis,?necrobiosis lipoidica. Proc R Soc Med (1969) 0.90
Erythrasma in a hospital for the mentally subnormal. Br J Dermatol (1970) 0.90
Carriage of Staphylococcus aureus in psoriasis. Br Med J (1968) 0.90
A rosacea-like eruption of children. Br J Dermatol (1972) 0.89
Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Cancer Res (1986) 0.89
Determination of the acetylator phenotype using matrix isoniazid. Tubercle (1975) 0.89
The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial. Br J Dermatol (2004) 0.89
Clinical and histological features of 'mechanic's hands' in a patient with antibodies to Jo-1--a case report. Clin Exp Dermatol (1994) 0.89
A method of liberating living cells from the dermal infiltrate. Br J Dermatol (1975) 0.88
Further studies of scratching during sleep. Br J Dermatol (1975) 0.88
Oral presentation of lymphoma: case report of T-cell lymphoma masquerading as oral Crohn's disease, and review of the literature. Eur J Cancer B Oral Oncol (1993) 0.87
The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves. Br J Pharmacol (1975) 0.87
The use of isoniazid as a marker to monitor the self-administration of medicaments. Br J Clin Pharmacol (1975) 0.87
Systemic lupus erythematosus with ectopic calcification. Br J Dermatol (1971) 0.87
Further studies on the pharmacology of a slow-release matrix preparation of isoniazid (Smith and Nephew HS 82) of potential use in the intermittent treatment of tuberculosis. Tubercle (1973) 0.87
Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various meals. Int J Antimicrob Agents (1994) 0.86
Clofazimine and dapsone compliance in leprosy. Lepr Rev (1988) 0.86
Determination of the acetylator phenotype in a Northern Nigerian population. Tubercle (1975) 0.85
Current causes of fixed drug eruption in the UK. Br J Dermatol (2001) 0.85
"Gram-negative" infections of the skin. Br J Dermatol (1971) 0.85
The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine. Tubercle (1973) 0.85
Nocturnal scratching and its relationship to the disturbed sleep of itchy subjects. Clin Exp Dermatol (1991) 0.84
Combined treatment for lepromatous leprosy. Lepr Rev (1980) 0.83
Glagov remodeling of the atherosclerotic aorta demonstrated by cardiovascular magnetic resonance: the CORDA asymptomatic subject plaque assessment research (CASPAR) project. J Cardiovasc Magn Reson (2004) 0.83
Virus-induced thymidine kinases as markers for typing herpes simplex viruses and for drug sensitivity assays. J Virol Methods (1982) 0.82
Letter: Circular regrowth in alopecia areata. Br J Dermatol (1975) 0.81
Antibody responses to Epstein-Barr virus-specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma. Int J Cancer (1982) 0.81
Chemotherapy of tuberculosis for patients with renal impairment. Nephron (1993) 0.81
The minimal inhibitory concentrations of sulphadimethozine and sulphadoxine against Mycobacterium leprae. Lepr Rev (1970) 0.81
Dermatology in Edinburgh: the first 100 years. Br Med J (Clin Res Ed) (1985) 0.81
A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man. J Antimicrob Chemother (1984) 0.80